Notice to the reader: The online consultation is now closed. Comments and suggestions received during the public consultation period are being considered in the finalization of this document. The final report will be made available as soon as possible.
13 February 2009
ISBN: 978-1-100-11460-6 (978-1-100-11461-3)
Cat. No.: H113-27/2009-2E (H113-27/2009-2E-PDF)
The text provided on this page reflects only the body of the report. To obtain an electronic copy of the complete document, including appendices (PRVD2009-02, Proposed Re-evaluation Decision: Quintozene, please contact our publications office.
Should you require further information please contact the Pest Management Information Service.
After a re-evaluation of the fungicide quintozene, Health Canada's Pest Management Regulatory Agency (PMRA), under the authority of the
Pest Control Products Act and Regulations, is proposing continued registration of products containing aliphatic alcohols for sale and use in Canada.
Products containing quintozene used on cole crops and for ornamental bulb dip treatments do not pose unacceptable risk to human health or the environment, and have value for agriculture when used according to the label directions. As a condition for continued registration of quintozene products, new risk-reduction measures will be required on product labels. In addition, the registrant must submit additional data as identified in this document.
Certain uses of quintozene are proposed for phase-out because the risk associated with these uses exceeds current health and environmental standards. They include all uses on turf and ornamentals (except bulb dip treatment).
Once the final re-evaluation decision is made, the registrants will be instructed on how to address any new requirements.
This Proposed Re-evaluation Decision (PRVD) is a consultation document1 that summarizes the science evaluation for quintozene and presents the reasons for the proposed re-evaluation decision.
The information is presented in two parts. The Overview describes the regulatory process and key points of the evaluation, while the Science Evaluation provides detailed technical information on the assessment of quintozene.
The PMRA will accept written comments on this proposal up to 45 days from the date of publication of this document. Please forward all comments to Publications (see contact information indicated on the cover page of this document).
The PMRA's pesticide re-evaluation program considers potential risks, as well as value, of pesticide products to ensure they meet modern standards established to protect human health and the environment. Regulatory Directive DIR2001-03, PMRA Re-evaluation Program, presents the details of the re-evaluation activities and program structure.
Quintozene, one of the active ingredients in the current re-evaluation cycle, has been re-evaluated under Re-evaluation Program 1. This program relies as much as possible on foreign reviews, typically the United States Environmental Protection Agency (USEPA) Reregistration Eligibility Decision (RED) documents. For products to be re-evaluated under Program 1, the foreign review must meet the following conditions:
Given the outcome of foreign reviews and a review of the chemistry of Canadian products, the PMRA will propose a re-evaluation decision and appropriate risk-reduction measures for Canadian uses of an active ingredient. In this decision, the PMRA takes into account the Canadian use pattern and issues (e.g. the federal Toxic Substances Management Policy [TSMP]).
Based on the health and environmental risk assessments published in the 2006 RED, the USEPA concluded that certain uses of quintozene were eligible for reregistration provided risk-reduction measures were adopted. The PMRA compared the American and Canadian use patterns and found that the USEPA assessments described in this RED were an adequate basis for the proposed Canadian re-evaluation decision.
For more details on the information presented in this overview, please refer to the Science Evaluation of this consultation document.
Quintozene is a fungicide that is currently used to control fungal diseases on cole crops, ornamentals and turf. As a fungicide, quintozene interferes with mitotic division and suppresses the sporulation. Quintozene can be applied by professional applicators.
People could be exposed to quintozene by consuming food and water, working as a mixer/loader/applicator or by entering treated sites. The PMRA considers two key factors when assessing health risks: the levels at which no health effects occur and the levels to which people may be exposed. The dose levels used to assess risks are established to protect the most sensitive human population (e.g. children and nursing mothers). Only uses for which exposure is well below levels that cause no effects in animal testing are considered acceptable for continued registration.
The USEPA concluded that quintozene was unlikely to affect human health provided that the following uses are phased-out: residential lawns, turf farms and ornamental uses (except bulb dip treatment). The USEPA's conclusions regarding residential lawns and ornamentals uses apply to the Canadian situation, and phase-out of these quintozene uses is proposed.
The Food and Drugs Act prohibits the sale of food containing a pesticide residue that exceeds the established maximum residue limit (MRL). Pesticide MRLs are established for Food and Drugs Act purposes through the evaluation of scientific data under the Pest Control Products Act. Each MRL value defines the maximum concentration in parts per million (ppm) of a pesticide allowed in/on certain foods. Food containing a pesticide residue that does not exceed the established MRL does not pose an unacceptable health risk.
Currently, quintozene is registered in Canada for use on cole crops. Quintozene could be used in other countries on crops that are imported into Canada. In Canada, the MRLs have been established for broccoli, Brussels sprouts, cabbage, cauliflower and ginseng. Where no specific MRL has been established, a default MRL of 0.1 ppm applies, which means that pesticide residues in a food commodity must not exceed 0.1 ppm. However, changes to this general MRL may be implemented in the future, as indicated in the Discussion Document DIS2006-01, Revocation of the 0.1 ppm as a General Maximum Residue Limit for Food Pesticide Residues [Regulation B.15.002(1)]. If and when the general MRL is revoked, a transition strategy will be established to allow permanent MRLs to be set.
Terrestrial and aquatic species could be exposed to quintozene in the environment. Environmental risk is assessed by the risk quotient method - the ratio of the estimated environmental concentration to the relevant effect's endpoint of concern. The resulting risk quotients are compared to corresponding levels of concern. A risk quotient less than the level of concern is considered a negligible risk to non-target organisms, whereas a risk quotient greater than the level of concern indicates some degree of risk.
The USEPA concluded that the reregistration of quintozene was acceptable provided that all turf uses were terminated and that the maximum application rate on cole crops was reduced. The USEPA's conclusions apply to the Canadian situation, and equivalent risk-reduction measures are proposed.
Labels of registered pesticide products include specific instructions for use. Directions include risk-reduction measures to protect human and environmental health. These directions must be followed by law. As a result of the re-evaluation of quintozene, the PMRA is proposing the following.
Data to clarify current levels of impurities of toxicological concern in technical grade quintozene are required. These data have been requested from the registrant and are required under section 19 of the Pest Control Products Act. The registrants of this active ingredient must provide these data or an acceptable scientific rationale to the PMRA within the time line specified in the section 19 letter.
Before making a final re-evaluation decision on quintozene, the PMRA will consider all comments received from the public in response to this consultation document. The PMRA will then publish a Re-evaluation Decision2 that will include the decision, the reasons for it, a summary of comments received on the proposed decision and the PMRA's response to these comments.
Quintozene (pentachloronitrobenzene) is an organochlorine fungicide currently registered in Canada for control of fungal diseases on cole crops, ornamentals and turf. As a fungicide, quintozene interferes with mitotic division and suppresses the sporulation.
Following the re-evaluation announcement for quintozene, the registrant of the technical grade active ingredient in Canada indicated their intention to support all quintozene uses included on the labels of commercial end-use products in Canada.
The PMRA used recent assessments of quintozene (pentachloronitrobenzene) from the USEPA. The USEPA RED document for quintozene, dated 2006, as well as other information on the regulatory status of quintozene in the United States can be found on the USEPA Pesticide Registration Status page at www.epa.gov/pesticides/reregistration/status.htm.
Active substance Quintozene
Function Fungicide
Chemical names:
IUPAC: Pentachloronitrobenzene
CAS: Pentachloronitrobenzene
Chemical class: Aromatic hydrocarbon
CAS number: 82-68-8
Molecular formula: C6Cl5NO2
Molecular weight: 295.34
Structural formula:

The following impurities of toxicological and environmental concern (DIR98-04) were present in the technical grade quintozene.
| Property | Result | Interpretation |
|---|---|---|
| Vapour pressure at 25°C | 12.7 mPa | High volatility |
| Ultraviolet (UV)/visible spectrum | not expected to absorb at λ>300 nm | Phototransformation is unlikely |
| Solubility in water at 22°C | 0.1 mg/L | Sparingly soluble in water |
| n-Octanol-water partition coefficient (Kow) | log Kow = 5.1 | Potential for bioaccumulation |
Quintozene is an organochlorine used to control fungal diseases on cole crops, ornamentals and turf. It is applied as a soil treatment (cole crops, ornamentals and turf) or as a dip treatment (ornamental bulbs). The end-use products currently registered in Canada are formulated as wettable powders and suspensions. Quintozene may be applied on:
The American and Canadian use patterns were compared. At the time of the USEPA RED, quintozene for use on cole crops, turf and ornamentals was registered in both the United States and Canada. In addition, quintozene was registered in the United States for use on vegetables, field crops and as a seed treatment. Canadian use sites and end-use product formulations are encompassed by those assessed in the USEPA RED. Some of the Canadian maximum application rates are different from the American maximum application rates. The difference in the rates is discussed in more detail in the risk-assessment sections. Generally, it was concluded that the USEPA's RED document for quintozene is an adequate basis for the re-evaluation of Canadian use of quintozene.
All current uses are being supported by the registrants and were, therefore, considered in the re-evaluation of quintozene. Appendix I lists all quintozene products that are registered as of 4 June 2008 under the authority of the Pest Control Products Act.
In their 2006 RED, the USEPA concluded that the end-use products formulated with quintozene met the safety standard under the American Food Quality Protection Act and would not pose unreasonable risks or adverse effects to humans and the environment if used according to the amended directions on the product labels.
Toxicology studies in laboratory animals describe potential health effects resulting from various levels of exposure to a chemical and identify dose levels at which no effects are observed. Unless there is evidence to the contrary, it is assumed that effects observed in animals are relevant to humans and that humans are more sensitive to effects of a chemical than the most sensitive animal species.
In Canada, exposure to quintozene may occur through consumption of food and water, through residential exposure, while working as a mixer/loader/applicator or by entering treated sites. The PMRA considers two key factors when assessing health risks: the levels at which no health effects occur and the levels to which people may be exposed. The dose levels used to assess risks are established to protect the most sensitive human population (e.g. children and nursing mothers).
Occupational risk is estimated by comparing potential exposures with the most relevant endpoint from toxicology studies being used to calculate a margin of exposure (MOE). This is compared to a target MOE incorporating safety factors protective of the most sensitive subpopulation. If calculated MOE is less than the target MOE, it does not necessarily mean that exposure will result in adverse effects, but mitigation measures to reduce risk would be required.
The USEPA's toxicological endpoints for assessing risk from occupational exposure are summarized in Appendix II.
Workers can be exposed to quintozene when mixing, loading or applying the pesticide and when entering a treated site for the purpose of maintaining and harvesting grass.
Among the exposure scenarios identified in the RED document, the following 13 exposure scenarios were considered relevant to the Canadian situation.
The USEPA determined that workers can be exposed to quintozene by the dermal and inhalation routes, while mixing/loading and/or applying the product or a combination of these activities. Separate dermal and inhalation handler exposure was estimated for different levels of protection.
The following occupational application scenarios resulted in estimated MOEs that were below the USEPA target MOE of 100 at the maximum level of protection and, therefore, were of concern:
As a result, the American registrant proposed discontinuing use of quintozene on turf farms, residential/commercial lawns and on ornamentals (other than bulb dip treatment).
Based on the risk assessment, the USEPA required basic personal protective equipment (PPE) for mixers, loaders and other handlers of wettable powder formulation.
The RED adequately addressed all potential mixer/loader/applicator exposure scenarios associated with the uses of products containing quintozene in Canada but, because of the difference between Canadian and the American rates, the following was concluded.
For the mixer/loader of wettable powder for turf farm treatment, the Canadian maximum application rate is 2.4 times lower than the assessed American rate and resulted in an acceptable MOE. Consequently, the USEPA conclusion that this scenario is of concern is not applicable to the Canadian rate.
The Canadian maximum application rate on cole crops (45.4 kg a.i./ha) is 1.35 times higher than the assessed American maximum application rate (33.7 kg a.i./ha). The inhalation MOE of 120 for the mixer/loader of wettable powder, at the highest level of protection, does not provide sufficient protection to account for the difference in application rate between the United States and Canada.
Therefore, based on conclusions regarding a mixer/loader/applicator risk in the RED document, the PMRA proposes the following.
The USEPA determined there is a low potential for occupational postapplication exposure when quintozene is applied as a transplant solution during seedling planting. Therefore, a postapplication assessment for agriculture use was not required.
The USEPA performed a risk assessment for the scenario associated with the highest potential for postapplication exposure, i.e. individuals re-entering quintozene treated areas for the purpose of turf-grass maintenance and harvesting. The assessment was based on a maximum application rate of 46 kg a.i./ha on turf. Resulting MOEs were not of concern and no mitigation measures were required by the USEPA.
As per the United States Worker Protection Standard, the USEPA required a restricted-entry interval of 12 hours to protect postapplication workers.
The RED adequately addressed potential exposure scenarios associated with the Canadian uses of quintozene, and the USEPA's conclusions are considered to be applicable to the Canadian situation. A restricted-entry interval of 12 hours is being proposed to be added to the Canadian label for agricultural use. The proposed label amendment is listed in Appendix III.
There are no domestic class end-use products containing quintozene registered in Canada; therefore, only residential postapplication exposure to quintozene treated lawns was considered in this review. The toxicological endpoints selected by the USEPA for assessment of risk from residential exposure are summarized in Appendix II.
The USEPA assessed the following scenarios of postapplication exposure from treated turf:
Based on the risk assessment the USEPA determined the following.
As a result, the American registrants voluntarily cancelled all residential turf uses.
The Canadian maximum application rate (18.8 kg a.i./ha) is 1.9 times lower than the assessed American rate (36 kg a.i./ha). The PMRA found that some of the USEPA's MOEs associated with oral non-dietary (hand-to-mouth and object to mouth activity) and dermal contact exposure (toddlers and adults) still represent a concern, and the USEPA's conclusions are considered relevant to the Canadian situation. Therefore, quintozene use on residential turf is proposed for phase-out in Canada.
No toxicological endpoint attributed to a single oral dose was identified in available toxicological studies on quintozene. Therefore, no acute dietary risk assessment for quintozene was performed by the USEPA.
A chronic dietary risk is estimated by determining how much of a pesticide residue may be ingested with the daily diet and comparing this potential exposure to an acceptable daily intake, which is the dose at which an individual could be exposed over the course of a lifetime and expect no adverse health effects. The acceptable daily intake is referred to as the ADI in Canada, and, in the RED, it is expressed as the chronic population-adjusted dose (cPAD). The ADI is based on a relevant endpoint from toxicology studies and on safety factors protective of the most sensitive subpopulation.
The USEPA's highly refined chronic dietary risk assessment was based on a reduced application rate on cole crops (25.3 kg a.i./ha) and used all available monitoring data and information on percentage of crops treated. The chronic risk assessment resulted in risk estimates below 100% of the cPAD for the general population and all subgroups. The highest estimated exposure, from food only, was for children 1-2 years of age, utilizing 34% of the cPAD.
The USEPA determined that surface water sources were more likely to be contaminated with quintozene than groundwater sources, because quintozene was found to be relatively immobile in soils. Quintozene may reach surface water through drift when applied as a spray, particularly with foliar applications (such as turf). Screening models were used to estimate quintozene concentrations in the ground and surface water. The estimated drinking water concentration (EDWC) from ground water sources was 30.6 ppb. The estimated drinking water concentrations from surface water were 88.8 ppb and 10.3 ppb for acute and chronic exposures, respectively. When water was added to the dietary risk analysis, the exposure was estimated to take up 79% of the cPAD for the most sensitive population subgroup, infants (less than one year old).
Cancer dietary exposure assessment was not required because quintozene was classified as an unquantified Group C (possible human) carcinogen, with a threshold effect observed in test animals. There was no concern for mutagenicity resulting from exposure to quintozene.
The USEPA's assessment encompassed Canadian registered uses of quintozene and is considered applicable to the Canadian situation.
The aggregate risk assessment conducted by the USEPA included dietary exposure (food and water) only because the risk associated with postapplication activities was of concern and residential uses on turf has been cancelled voluntarily by the American registrant. The aggregated exposure to quintozene residues in/on food and water represented 79% of the cPAD for the most sensitive population subgroup, infants (less than one year old).
Overall, the Canadian aggregate exposure scenario was adequately addressed by the USEPA aggregate risk assessment, and the USEPA aggregate exposure conclusions are considered applicable to quintozene uses in Canada, provided that residential turf uses are phased out.
The USEPA has not determined whether quintozene has a common mechanism of toxicity with other substances or whether it shares a toxic metabolite produced by other substances. Therefore, it was assumed that quintozene does not share a common mechanism of toxicity with other substances and a cumulative risk assessment was not required.
The USEPA determined the following.
To assess the ecological risk of quintozene to both terrestrial and aquatic non-target plants and animals, the USEPA calculated risk quotients (RQs) based on appropriate toxicity endpoints and expected environmental concentrations (EECs) and compared the resulting RQs to corresponding levels of concern (LOCs).
The USEPA environmental risk was based on the maximum application rate on turf (48.7 kg a.i./ha) and cabbage (25.3 kg a.i./ha, a reduced application rate proposed by the American registrant). The USEPA determined the following.
No chronic toxicity data were available for estuarine/marine animals; however, given estuarine/marine organisms were more sensitive to quintozene on an acute basis than their freshwater counterparts, the USEPA determined that they would be also more sensitive on a chronic basis.
The USEPA determined the following.
The American use pattern for quintozene generally encompasses the Canadian use pattern. Although the Canadian maximum application rate on turf is 2.6 times lower than the American rate, the risk to mammals and birds would still remain of concern. Therefore, the USEPA's assessment and conclusions are considered relevant to the Canadian situation and the following mitigation measures are proposed by the PMRA:
The PMRA is currently developing a policy for managing chemicals that are persistent, bioaccumulative and toxic. Quintozene is considered to have persistent bioaccumulative and toxic characteristics and will be revisited once an approach has been developed.
The management of toxic substances is guided by the 1995 federal TSMP, which puts forward a preventive and precautionary approach to deal with substances that enter the environment and could harm the environment or human health. The policy provides decision makers with direction and sets out a science-based management framework to ensure that federal programs are consistent with its objectives. One of the key management objectives is virtual elimination from the environment of toxic substances that result predominantly from human activity and that are persistent and bioaccumulative. These substances are referred to in the policy as Track 1 substances.
The federal TSMP and PMRA Regulatory Directive DIR99-03, The Pest Management Regulatory Agency's Strategy for Implementing the Toxic Substances Management Policy, were taken into account during the re-evaluation of quintozene, which led to the following conclusions.
Formulant issues are being addressed through PMRA formulant initiatives and Regulatory Directive DIR2006-02, Formulants Policy and Implementation Guidance Document, published on 31 May 2006.
Canada is part of the Organisation for Economic Co-operation and Development (OECD), which groups 30 member countries and provides governments with a setting in which to discuss, develop and perfect economic and social policies. They compare experiences, share information and analyses, seek answers to common problems, and work to co-ordinate domestic and international policies to allow for consistency in practices across nations.
Based on the current available information on the status of quintozene in the OECD member countries, it was found that quintozene was prohibited due to health and/or environmental concerns in Sweden (1985),3 Finland (1996),4 the Republic of Korea (1987; PIC circular X),5 Germany (1988; PIC circular X),5 Austria (1992; PIC circular X),5 Switzerland (1992; PIC circular XX).5 In 2000, due to concerns of the risk to human health, persistence in the environment and possible impact on non-target organisms, quintozene products were prohibited by the European Union.6 In 2006, based on the concerns for human health and the environment, the United States, also an OECD member, found quintozene use on turf and ornamentals (except bulb dip) not eligible for re-registration.
The Canadian re-evaluation of quintozene is largely based on the 2006 USEPA assessment. The PMRA has found the USEPA's conclusions, pertaining to human health and environmental risk, to be relevant to quintozene use in Canada. The same measures to reduce potential risk to human health and environment are proposed by the PMRA.
The concerns identified in the OECD countries relating to human health and environmental risk associated with quintozene was taken into consideration in the re-evaluation of quintozene in Canada and have been addressed in the proposed Canadian re-evaluation decision.
After a re-evaluation of the fungicide quintozene, Health Canada's Pest Management Regulatory Agency (PMRA), under the authority of the Pest Control Products Act and Regulations, is proposing continued registration of certain products containing quintozene for the sale and use in Canada.
Products containing quintozene used on cole crops and for ornamental bulb dip do not pose unacceptable risk to human health or the environment and have value for agriculture when used according to the label directions. As a condition for continued registration of quintozene products, the following new risk-reduction measures will be required.
Certain uses of quintozene are proposed for phase-out because the risk associated with these uses exceeded current health and environmental standards. They include all products for turf and ornamental uses (except bulb dip treatment).
The PMRA is currently developing a policy for managing chemicals that are persistent, bioaccumulative and toxic (persistent bioaccumulative and toxic). Quintozene is considered to have persistent bioaccumulative and toxic characteristics and will be revisited once an approach has been developed.
Further measures may be necessary pending the outcome of the TSMP assessment regarding the impurities of toxicological concerns.
Additional data regarding impurities of toxicological concern have been requested from the registrant and are required under section 19 of the Pest Control Products Act.
PMRA documents, such as Regulatory Directive DIR2001-03, and data code (DACO) tables can be found on our website at Pesticides and Pest Management. PMRA documents are also available through the Pest Management Information Service. Phone: 1-800- 267-6315 within Canada or 1-613-736-3799 outside Canada (long distance charges apply);
fax: 613-736-3798;
e-mail: pmra_infoserv@hc-sc.gc.ca.
The federal TSMP is available through
Environment Canada's website.
The USEPA RED document for quintozene (pentachloronitrobenzene) is available on the USEPA
Pesticide Registration Status page.
1 "Consultation statement" as required by subsection 28(2) of the Pest Control Products Act.
2 "Decision statement" as required by subsection 28(5) of the Pest Control Products Act.
3 Swedish Chemicals Agency's Regulations on Chemical Products and Biotechnical Organisms (KIFS 1998:8) Appendix 5.
4 Finish Food Safety Authority EVIRA.
5 Prior informed consent (PIC) circulars are published by the Rotterdam Convention Secretariat. Under this Convention, parties to the Convention have committed to inform other parties about legislative bans or severe restrictions on the use of chemicals and to notify recipient countries of any exports of regulated substances. This procedure is called Prior Informed Consent (PIC). When a party has adopted a final regulatory action to ban or severely restrict a chemical, the party notifies the Rotterdam Convention Secretariat; notifications are published in PIC circulars.
6 European Union Directive 79/117/EEC (1991) (00/816) Regulatory Decision excluding substances from Annex I of Directive 91/414.